EC

Euclidean Capital Portfolio holdings

AUM $306M
1-Year Est. Return 16.69%
This Quarter Est. Return
1 Year Est. Return
+16.69%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$306M
AUM Growth
+$39.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
11
New
Increased
Reduced
Closed

Top Buys

1 +$10.1M

Top Sells

1 +$24

Sector Composition

1 Healthcare 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VEU icon
1
Vanguard FTSE All-World ex-US ETF
VEU
$51B
$144M 47.11%
2,142,684
+150,800
INDA icon
2
iShares MSCI India ETF
INDA
$9.57B
$135M 44.17%
2,425,144
ORIC icon
3
Oric Pharmaceuticals
ORIC
$1.24B
$10M 3.28%
989,410
FHTX icon
4
Foghorn Therapeutics
FHTX
$226M
$7.4M 2.42%
1,573,761
PMVP icon
5
PMV Pharmaceuticals
PMVP
$74.2M
$2.79M 0.91%
2,627,643
SPY icon
6
SPDR S&P 500 ETF Trust
SPY
$660B
$2.54M 0.83%
4,104
ALEC icon
7
Alector
ALEC
$308M
$1.83M 0.6%
1,307,858
SRZN icon
8
Surrozen
SRZN
$116M
$784K 0.26%
87,696
RAPT icon
9
RAPT Therapeutics
RAPT
$485M
$658K 0.22%
82,234
-3
TNYA icon
10
Tenaya Therapeutics
TNYA
$295M
$621K 0.2%
1,015,705
SRZNW icon
11
Surrozen Inc Warrant
SRZNW
$36K
$3.09K ﹤0.01%
170,833